讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月27日南向资金增持2.6万股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持9.85万股。近20个交易日中，获南向资金增持的有11天，累计净增持12.06 万股。截至目前，南向资金持有讯飞医疗科技（02506.HK）523.32万股，占公司已发行普通股的 6.76%。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 证券之星消息，2月26日南向资金减持4000.0股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持8.58万股。近20个交易日中，获南向资金增持的有10天，累计净增持5.79万 股。截至目前，南向资金持有讯飞医疗科技（02506.HK）520.72万股，占公司已发行普通股的6.73%。 ...

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 13,400 shares on February 12, indicating a fluctuating interest from investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings, totaling a decrease of 227,900 shares [1] - In the last twenty trading days, there were ten days of net increases, with a total increase of 326,000 shares [1] - As of now, southbound funds hold 5,134,800 shares of iFlytek Medical Technology, representing 6.63% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (comprising intelligent medical assistants and chronic disease management), hospital services (including smart hospital solutions and diagnostic assistants), and patient services (such as smart hospital patient services and post-discharge management) [1] - The regional management platform solutions business line includes smart health solutions and smart medical insurance [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 186,500 shares on February 10, 2026, marking a decrease of 3.44% [1][2] - Over the past five trading days, there have been four days of reductions in holdings, totaling a net decrease of 210,700 shares [1] - In the last 20 trading days, there were 11 days of increased holdings, with a cumulative net increase of 1,308,000 shares [1] Group 2 - As of now, southbound funds hold 5,231,600 shares of iFlytek Medical Technology, which represents 6.76% of the company's total issued ordinary shares [1] - The company primarily engages in providing AI-powered medical solutions, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]

Core Viewpoint - Southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 9,400 shares on February 5, indicating a potential shift in investor sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past 5 trading days, there were 2 days of net purchases by southbound funds, totaling an increase of 104,500 shares [1] - In the last 20 trading days, there were 12 days of net purchases, with a cumulative increase of 1,634,000 shares [1] - Currently, southbound funds hold 5,362,600 shares of iFlytek Medical Technology, representing 6.93% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management, including the iFlytek Xiaoyi App and mini-programs) [1] - The regional management platform solutions business line encompasses smart health solutions and smart medical insurance [1] - The company mainly operates in the domestic market [1]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company [1]. Group 1: Shareholding Changes - On January 23, 2026, southbound capital held a total of 5.1505 million shares of iFlytek Medical Technology, with an increase of 37,900 shares, representing a change of 0.74% [2]. - Over the past five trading days, there were two days of net increases in holdings, totaling 36,900 shares [1]. - In the last 20 trading days, there were eight days of net increases, accumulating to 1.1123 million shares [1]. Group 2: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-powered medical solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - The grassroots medical services include intelligent medical assistants and chronic disease management [2]. - The hospital services encompass smart hospital solutions and diagnostic assistance, while patient services involve smart hospital patient services and post-discharge management [2].

Core Insights - The healthcare insurance department is focused on optimizing medical insurance services to address public concerns and improve efficiency in the sector [1][2] Group 1: Enhancements in Medical Insurance Services - The initiative includes advancing "smart medical insurance" construction, enhancing information platform functionalities, and streamlining business processes [1] - The promotion of digital applications such as electronic medical insurance credentials and mobile payments aims to expand the coverage of "face recognition" settlement [1] - The optimization of online business processes and the enhancement of cross-province personal account usage are key objectives [1] Group 2: Improvement in Service Capabilities - The implementation of a clear list of medical insurance service items and the standardization of service processes and timelines are prioritized [1] - The establishment of standardized service windows and demonstration points is part of the effort to improve service efficiency [1] - The initiative includes a targeted training program for staff to enhance their capabilities and ensure they meet the needs of the public [1] Group 3: Timely Settlement Capabilities - The focus is on optimizing the settlement process with designated medical institutions, improving review processes, and enhancing data integration [2] - Aiming for a settlement timeline where expenses are reported in the current month and settled in the following month [2] - The establishment of a three-tiered monitoring mechanism for real-time oversight of fund settlement and disbursement is being explored [2] Group 4: Data Security and Efficiency - The integration of medical insurance with commercial health insurance and charitable assistance for a one-stop settlement process is being promoted [2] - Emphasis on data security while enhancing the efficiency of multi-level medical insurance settlements through improved verification processes [2] - Strict measures are in place to ensure fund security and prevent fraudulent claims while supporting the healthy development of medical institutions [2]

Core Viewpoint - The company Shanda Diwei is undergoing significant changes, including a change in its controlling shareholder to Shandong High-speed Group and a proposed name change to Diwei Intelligent Technology Co., Ltd. This transition aims to enhance its business scope and leverage resources from its new parent company [3][4]. Group 1: Shareholder and Control Changes - In November 2025, Shanda Diwei's controlling shareholder will change from Shandong Shanda Capital Operation Co., Ltd. to Shandong High-speed Group, with the actual controller shifting from Shandong University to the Shandong Provincial State-owned Assets Supervision and Administration Commission [3]. - The company plans to change its name to Diwei Intelligent Technology Co., Ltd. and its stock abbreviation to Diwei Intelligent [3]. Group 2: Business Scope and Financial Performance - Shanda Diwei intends to expand its business scope to include information system integration services, blockchain technology-related software and services, data processing and storage support services, and internet data services [3]. - For the first three quarters of 2025, Shanda Diwei reported revenue of 326 million yuan, a year-on-year decrease of 0.89%, while net profit attributable to shareholders was 31.52 million yuan, an increase of 1.30% [3]. Group 3: Strategic Partnerships and Transactions - Following the transfer to Shandong High-speed Group, Shanda Diwei is expected to leverage the latter's resources to gain entry into transportation sector scenarios [4]. - The company anticipates selling products and services worth 70 million yuan to Shandong High-speed Group and its affiliates in 2026, which would account for 97.75% of similar business transactions [4]. Group 4: Board of Directors and Governance - The board of directors' election announcement indicates the nomination of several candidates with backgrounds in Shandong High-speed Group for the fifth board of directors [6]. - The company will hold its first extraordinary shareholders' meeting of 2026 on February 6, 2026, to review related proposals [8]. Group 5: Financial Management - Shanda Diwei plans to utilize up to 300 million yuan of temporarily idle funds for cash management over a 12-month period [7].

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 3,500 shares on January 8, with a total net reduction of 193,900 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in southbound fund holdings, totaling 215,500 shares [1] - As of now, southbound funds hold 3,728,700 shares of iFlytek Medical Technology, which represents 4.82% of the company's total issued ordinary shares [1] Group 2 - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services, hospital services, patient services, and regional management platform solutions [1] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [1]

Core Viewpoint - Recent trading activity indicates a reduction in holdings by southbound funds in iFlytek Medical Technology, suggesting potential shifts in investor sentiment towards the company [1] Group 1: Trading Activity - On December 22, southbound funds reduced their holdings by 40,900 shares of iFlytek Medical Technology (02506.HK) [1] - Over the past five trading days, there have been four days of net reductions, totaling 107,900 shares [1] - In the last 20 trading days, there were 14 days of net increases, with a total of 91,600 shares added [1] - Currently, southbound funds hold 3,978,600 shares of iFlytek Medical Technology, representing 5.14% of the company's issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-diagnosis management) [1] - The company also offers regional management platform solutions, including smart health solutions and smart medical insurance [1] - iFlytek Medical Technology mainly operates in the domestic market [1]